In 2023, Brazil led in female mortality from skin and subcutaneous tissue diseases with 18.69%, followed by the United States (13.79%) and Mexico (11.14%). Significant year-on-year changes include Poland's increase of 12.45% and Estonia's surge of 22.1%. Conversely, Israel and Costa Rica saw declines of 0.97% and 1.78%, respectively. CAGR highlights include Portugal's 18.19% growth rate, indicating a notable upward trend compared to other countries.
Future trends to monitor include ongoing shifts in healthcare practices globally, emerging preventive measures, and advancements in dermatological treatments, which may lead to declines in skin-related mortality rates, particularly in developed nations. Monitoring technological and pharmaceutical advancements will be key in understanding and predicting these shifts.
Top countries in Skin and Subcutaneous Tissue Diseases Mortality Share by Country (Units (Female Deaths))
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Brazil | 18.69 | 2023 | +3.86% | +4.75% | View data |
| 2 | 2 United States | 13.79 | 2023 | +1.18% | +2.27% | View data |
| 3 | 3 Mexico | 11.14 | 2023 | +11.1% | +4.92% | View data |
| 4 | 4 Argentina | 8.24 | 2023 | +6.17% | +3.31% | View data |
| 5 | 5 Japan | 7.92 | 2023 | +2.81% | +3.03% | View data |
| 6 | 6 United Kingdom | 6.22 | 2023 | +1.1% | +0.81% | View data |
| 7 | 7 Spain | 5.7 | 2023 | +2.44% | +2.55% | View data |
| 8 | 8 Germany | 4.45 | 2023 | +0.67% | +1.02% | View data |
| 9 | 9 South Africa | 4.16 | 2023 | +2.19% | +1.85% | View data |
| 10 | 10 Colombia | 3.45 | 2023 | +0.99% | +3.66% | View data |
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...
